Search research articles
Contact Us
Filters
Showing results (171-180 of 252) with videos related to
Page
of 26
Sort By:
ESMO Open
|
December 8, 2017
Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial
Eric Van Cutsem, Alfredo Falcone, Rocio Garcia-Carbonero, et al.
Biomedical Research (Tokyo, Japan)
|
August 21, 2022
Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients
Yuji Shimoda, Takeshi Nagashima, Kenichi Urakami, et al.
Clinical Colorectal Cancer
|
March 14, 2018
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Eiji Oki, Takeshi Kato, Hideaki Bando, et al.
Journal of Global Oncology
|
August 8, 2018
Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials
Chia-Jui Yen, Kei Muro, Tae-Won Kim, et al.
The Oncologist
|
November 11, 2023
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G)
Yosuke Kito, Hisato Kawakami, Seiichiro Mitani, et al.
Cancer
|
March 25, 2025
A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G)
Nozomu Machida, Takehiro Okumura, Narikazu Boku, et al.
Journal of the Anus, Rectum and Colon
|
August 1, 2024
Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)
Kozo Kataoka, Takeshi Yamada, Kentaro Yamazaki, et al.
Scientific Reports
|
December 6, 2023
Development of a nomogram to predict survival in advanced biliary tract cancer
Hiroshi Imaoka, Masafumi Ikeda, Shogo Nomura, et al.
Eclinicalmedicine
|
February 9, 2026
Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan
Kenro Hirata, Yasuo Hamamoto, Hirokazu Shoji, et al.
Targeted Oncology
|
September 22, 2020
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)
Naoki Izawa, Kohei Shitara, Kimio Yonesaka, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 252) with videos related to
Sort By:
Page
of 26
ESMO Open
|
December 8, 2017
Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial
Eric Van Cutsem, Alfredo Falcone, Rocio Garcia-Carbonero, et al.
Biomedical Research (Tokyo, Japan)
|
August 21, 2022
Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients
Yuji Shimoda, Takeshi Nagashima, Kenichi Urakami, et al.
Clinical Colorectal Cancer
|
March 14, 2018
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Eiji Oki, Takeshi Kato, Hideaki Bando, et al.
Journal of Global Oncology
|
August 8, 2018
Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials
Chia-Jui Yen, Kei Muro, Tae-Won Kim, et al.
The Oncologist
|
November 11, 2023
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G)
Yosuke Kito, Hisato Kawakami, Seiichiro Mitani, et al.
Cancer
|
March 25, 2025
A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G)
Nozomu Machida, Takehiro Okumura, Narikazu Boku, et al.
Journal of the Anus, Rectum and Colon
|
August 1, 2024
Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)
Kozo Kataoka, Takeshi Yamada, Kentaro Yamazaki, et al.
Scientific Reports
|
December 6, 2023
Development of a nomogram to predict survival in advanced biliary tract cancer
Hiroshi Imaoka, Masafumi Ikeda, Shogo Nomura, et al.
Eclinicalmedicine
|
February 9, 2026
Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan
Kenro Hirata, Yasuo Hamamoto, Hirokazu Shoji, et al.
Targeted Oncology
|
September 22, 2020
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)
Naoki Izawa, Kohei Shitara, Kimio Yonesaka, et al.
Page
of 26